CAD 0.01
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.98 Million CAD | -5.12% |
2022 | 2.09 Million CAD | 6.33% |
2021 | 1.96 Million CAD | 2.06% |
2020 | 1.92 Million CAD | 136.0% |
2019 | 816.65 Thousand CAD | 174.69% |
2018 | 297.3 Thousand CAD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 258.25 Thousand CAD | -6.64% |
2024 Q1 | 234.96 Thousand CAD | -29.02% |
2023 Q4 | 331 Thousand CAD | -26.35% |
2023 FY | 1.81 Million CAD | -13.13% |
2023 Q1 | 430.41 Thousand CAD | -53.52% |
2023 Q3 | 449.41 Thousand CAD | -30.63% |
2023 Q2 | 647.88 Thousand CAD | 50.52% |
2022 Q2 | 378.3 Thousand CAD | 16.63% |
2022 FY | 2.09 Million CAD | 6.33% |
2022 Q4 | 926.1 Thousand CAD | 100.14% |
2022 Q3 | 462.72 Thousand CAD | 22.31% |
2022 Q1 | 324.36 Thousand CAD | -49.98% |
2021 FY | 1.96 Million CAD | 2.06% |
2021 Q2 | 407.42 Thousand CAD | -1.63% |
2021 Q1 | 414.18 Thousand CAD | -34.51% |
2021 Q3 | 496.95 Thousand CAD | 21.98% |
2021 Q4 | 648.42 Thousand CAD | 30.48% |
2020 FY | 1.92 Million CAD | 136.0% |
2020 Q1 | 331.24 Thousand CAD | 5.61% |
2020 Q3 | 493.84 Thousand CAD | 4.35% |
2020 Q2 | 473.26 Thousand CAD | 42.87% |
2020 Q4 | 632.47 Thousand CAD | 28.07% |
2019 Q4 | 313.65 Thousand CAD | 56.73% |
2019 Q3 | 200.12 Thousand CAD | 21.14% |
2019 Q1 | 123.79 Thousand CAD | 75.11% |
2019 FY | 816.65 Thousand CAD | 174.69% |
2019 Q2 | 165.19 Thousand CAD | 33.44% |
2018 Q3 | 116.25 Thousand CAD | 182.31% |
2018 FY | 297.3 Thousand CAD | 0.0% |
2018 Q4 | 70.69 Thousand CAD | -39.19% |
2018 Q2 | 41.18 Thousand CAD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aquarius Surgical Technologies Inc. | 591.58 Thousand CAD | -235.445% |
Cannabix Technologies Inc. | 2.96 Million CAD | 32.995% |